COVID-19
-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say.
-
National COVID-19 trends, June 23
COVID-19 levels remain very low across much of the U.S. as a deep lull between waves continues — at least, as far as we can tell from viral levels in wastewater, which do not translate directly to infections. However, there are accumulating signals that a summer wave may start soon, particularly in parts of the…
-
National COVID-19 trends, June 16
The U.S.’s low lull in COVID-19 spread continues. Disease levels in wastewater and healthcare data remain very low through early June. While there are possible increases in some places, particularly in the Midwest and South, it’s unclear if a summer wave — which we’ve seen every year since the pandemic began — is starting soon.…
-
National COVID-19 trends, June 9
National COVID-19 estimates have remained very low in the U.S. through the end of May. There are signals of potential increases in some locations, but it’s hard to say if these represent isolated outbreaks or the start of a summer wave. Meanwhile, future funding for wastewater surveillance is under threat.
-
National COVID-19 trends, June 2
A record-breaking COVID-19 lull has continued in the U.S. through late May. The latest national estimates for SARS-CoV-2 spread are the lowest they have been since spring 2021. While there are signs of possible case increases in some locations, these are preliminary and difficult to interpret.
-
National COVID-19 trends, May 26
In recent weeks, U.S. COVID-19 metrics have remained very low, with wastewater surveillance providers reporting their lowest national averages in several years. However, the most recent data suggest the lull may come to an end soon, as cases may be starting to increase in parts of the South.
-
Research updates, May 26
More research articles
-
COVID-19 spreads year round. Here’s how to track it.
Our webinar answered common questions about following data for COVID-19 and other infectious diseases.
-
National COVID-19 trends, May 5
A historic COVID-19 lull in the U.S. has continued through late April. Disease levels in wastewater and as measured by the healthcare system are at their lowest in several years; I’m surprised to see this considering the continued lack of widespread health measures. BA.3.2 (or “Cicada”) remains on the horizon but doesn’t appear to be…
-
National COVID-19 trends, April 28
The U.S. is still in a lull between COVID-19 waves, as of mid-April, and the latest data indicate the lowest levels in a couple of years — maybe the lowest possible without more widespread precautions. BA.3.2 (or “Cicada”) is still on the horizon, but having limited impacts on U.S. cases so far.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
I worked in homeless services for years. It didn’t help me find accessible housing when I got Long COVID.
-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
-
National COVID-19 trends, June 23
-
Research updates, June 23
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance